Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 10 11:54AM ET
135.00
Dollar change
-1.55
Percentage change
-1.13
%
Index- P/E- EPS (ttm)-0.04 Insider Own6.98% Shs Outstand55.77M Perf Week-2.90%
Market Cap7.56B Forward P/E71.59 EPS next Y1.89 Insider Trans-1.24% Shs Float52.09M Perf Month-5.85%
Income-1.90M PEG- EPS next Q0.33 Inst Own103.82% Short Float7.30% Perf Quarter7.21%
Sales602.35M P/S12.55 EPS this Y-17.67% Inst Trans-0.76% Short Ratio4.67 Perf Half Y-23.33%
Book/sh35.53 P/B3.80 EPS next Y30.89% ROA-0.07% Short Interest3.80M Perf Year-13.02%
Cash/sh14.45 P/C9.35 EPS next 5Y27.00% ROE-0.10% 52W Range110.45 - 211.13 Perf YTD-24.91%
Dividend Est.- P/FCF63.40 EPS past 5Y15.08% ROI-0.07% 52W High-36.06% Beta0.95
Dividend TTM- Quick Ratio5.56 Sales past 5Y31.42% Gross Margin42.18% 52W Low22.23% ATR (14)5.13
Dividend Ex-Date- Current Ratio6.65 EPS Y/Y TTM-101.36% Oper. Margin2.51% RSI (14)40.00 Volatility3.04% 3.53%
Employees1783 Debt/Eq0.37 Sales Y/Y TTM-17.41% Profit Margin-0.32% Recom1.44 Target Price193.50
Option/ShortYes / Yes LT Debt/Eq0.33 EPS Q/Q-83.34% Payout0.00% Rel Volume0.17 Prev Close136.55
Sales Surprise-0.03% EPS Surprise1.20% Sales Q/Q-3.20% EarningsJul 30 BMO Avg Volume815.24K Price135.00
SMA20-4.25% SMA50-8.94% SMA200-16.94% Trades Volume54,723 Change-1.13%
Date Action Analyst Rating Change Price Target Change
Aug-28-24Initiated Wells Fargo Overweight $180
Jun-26-24Upgrade Deutsche Bank Hold → Buy $180 → $155
Jun-18-24Initiated Guggenheim Neutral
Dec-04-23Downgrade The Benchmark Company Buy → Hold
Jul-20-23Initiated Wells Fargo Overweight $185
Jul-05-23Resumed JP Morgan Overweight $220
Mar-28-23Initiated The Benchmark Company Buy $230
Dec-14-22Initiated Deutsche Bank Hold $180
Dec-07-22Initiated RBC Capital Mkts Sector Perform $190
Jul-20-22Initiated UBS Buy $213
Oct-04-24 11:15PM
Oct-03-24 11:55AM
Sep-24-24 07:30AM
Sep-11-24 06:35AM
Sep-09-24 05:20AM
07:37AM Loading…
Sep-07-24 07:37AM
Aug-29-24 11:31AM
Aug-23-24 08:43AM
07:30AM
Aug-16-24 04:39AM
Aug-02-24 07:09AM
Jul-31-24 10:46AM
12:30AM
Jul-30-24 08:45AM
07:45AM
07:30AM Loading…
07:30AM
02:55AM
Jul-29-24 04:00PM
Jul-23-24 10:01AM
Jul-20-24 08:21AM
Jul-16-24 07:30AM
Jun-24-24 07:33AM
Jun-15-24 02:50AM
02:50AM
Jun-14-24 11:43AM
Jun-13-24 07:00AM
Jun-03-24 08:00AM
May-31-24 11:31AM
May-23-24 02:12AM
May-22-24 07:30AM
09:53AM Loading…
May-15-24 09:53AM
May-07-24 07:30AM
May-02-24 11:31AM
11:31AM
11:23AM
03:06AM
May-01-24 11:53AM
09:11AM
08:50AM
08:47AM
07:47AM
07:30AM
Apr-23-24 11:43AM
Apr-17-24 07:30AM
Apr-12-24 10:07AM
09:49AM
Mar-19-24 07:30AM
Mar-12-24 01:18AM
Feb-27-24 02:02AM
Feb-24-24 12:03AM
Feb-22-24 11:24AM
10:39AM
Feb-21-24 08:45AM
08:12AM
07:51AM
07:30AM
Feb-07-24 07:30AM
Jan-31-24 12:10PM
Jan-29-24 05:09AM
Dec-19-23 07:30AM
Dec-18-23 04:49AM
Dec-07-23 07:30AM
Nov-30-23 11:31AM
Nov-15-23 07:15AM
Nov-14-23 02:01PM
07:30AM
Nov-07-23 07:30AM
Nov-02-23 07:30AM
Nov-01-23 12:10PM
11:46AM
12:04AM
Oct-31-23 09:41AM
09:12AM
08:50AM
07:41AM
07:30AM
Oct-25-23 10:01AM
Oct-24-23 10:00AM
Oct-17-23 11:44AM
07:30AM
Oct-02-23 07:30AM
Sep-27-23 06:51AM
Sep-26-23 12:41PM
07:30AM
Sep-14-23 10:10AM
Sep-12-23 07:30AM
Sep-06-23 03:06AM
Sep-01-23 12:19PM
11:31AM
07:30AM
Aug-21-23 06:53AM
Aug-17-23 08:00AM
Aug-10-23 09:39AM
Aug-09-23 06:10AM
Aug-03-23 11:19AM
Aug-02-23 08:55AM
07:49AM
07:30AM
Jul-31-23 09:08AM
Jul-26-23 10:02AM
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hunt AnthonyDirectorSep 10 '24Option Exercise33.8710,000338,700162,031Sep 12 11:35 AM
Hunt AnthonyDirectorSep 10 '24Sale145.3722,1913,225,927139,840Sep 12 11:35 AM
Hunt AnthonyOfficerSep 10 '24Proposed Sale144.7222,1913,211,481Sep 10 04:03 PM
KURIYEL RALFSenior VP, R&DAug 02 '24Option Exercise86.1017515,06712,463Aug 05 09:56 PM
KURIYEL RALFSenior VP, R&DAug 02 '24Sale159.357,1481,139,01612,288Aug 05 09:56 PM
Ralf KuriyelSenior Vice PresidentAug 02 '24Proposed Sale159.357,1481,139,040Aug 02 03:26 PM
KURIYEL RALFSenior VP, R&DAug 01 '24Sale165.674,465739,71719,261Aug 01 08:47 PM
MUIR GLENN PDirectorAug 01 '24Option Exercise36.295,000181,45013,283Aug 01 05:04 PM
Christine GebskiSenior Vice PresidentAug 01 '24Proposed Sale167.002,160360,720Aug 01 04:11 PM
Ralf KuriyelSenior Vice PresidentAug 01 '24Proposed Sale165.674,465739,705Aug 01 04:07 PM
Madaus Martin DDirectorJun 14 '24Buy124.941,615201,7764,613Jun 14 06:07 PM
BARTHELEMY NICOLASDirectorJun 14 '24Buy125.451,200150,5404,668Jun 14 05:42 PM
Hunt AnthonyChief Executive OfficerJun 14 '24Buy124.082,000248,160165,177Jun 14 05:41 PM
DAWES KAREN ADirectorJun 14 '24Option Exercise67.712,953199,94888,170Jun 14 05:33 PM
Hunt AnthonyChief Executive OfficerMay 21 '24Sale168.2620,0723,377,283163,177May 22 05:14 PM
KURIYEL RALFSenior VP, R&DMar 11 '24Option Exercise86.101,271109,43327,777Mar 12 08:24 PM
KURIYEL RALFSenior VP, R&DMar 11 '24Sale193.733,517681,34824,260Mar 12 08:24 PM
Hunt AnthonyChief Executive OfficerMar 08 '24Option Exercise16.55117201,956Mar 11 07:43 PM
Hunt AnthonyChief Executive OfficerMar 08 '24Sale197.4416,7073,298,632185,249Mar 11 07:43 PM
DAWES KAREN ADirectorFeb 27 '24Option Exercise42.074,626194,61688,367Feb 28 09:56 PM
DAWES KAREN ADirectorFeb 27 '24Sale193.351,000193,35087,367Feb 28 09:56 PM
Bylund JamesChief Operating OfficerFeb 23 '24Option Exercise94.3394088,67018,508Feb 26 08:38 PM
Bylund JamesChief Operating OfficerFeb 23 '24Sale198.084,373866,20414,135Feb 26 08:38 PM
Gebski ChristineSee RemarksNov 10 '23Sale147.133,788557,32828,787Nov 13 05:10 PM